AzTrials
AzTrials

Chronic Venous InsufficiencyTIREDNCT05662761

Assessment of the Relationship Between Severity of Chronic Venous Obstruction and Venous Claudication

An observational study of Chronic Venous Insufficiency, run by RWTH Aachen University at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Assessment of the Relationship between Severity of Chronic Venous Obstruction and Venous Claudication Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Chronic Venous Insufficiency
How many people
100 participants
Where
1 siteGermany
Study dates
31 Mar 2022to 30 Dec 2025
How long will I take part?
24 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients with obstruction in the common femoral vein, external iliac vein, common iliac vein, or inferior vena cava

Who may be able to join

  • Patients with an obstruction in the femoral vein communis, V. iliaca externa, V. iliaca communis or V. cava inferior
  • Age: 18-80 years old
  • Signed informed consent form
  • Persons who are legally competent and mentally capable, to follow the instructions of the staff

Who cannot join

  • Patients under 18 years of age.
  • Patients who are unable to consent and/or not in are able to appreciate the nature, importance and scope of the study understand and give their consent in writing.
  • Persons acting by administrative or judicial order are housed in a facility
  • Patients who abuse drugs
  • Peripheral arterial disease stage IIb, III and IV -

Trial locations and contacts

1 site in 1 country.

Mohammad E Barbati, MD contact

+492418035292

mbarbati@ukaachen.de

Gaby Heuer, SN contact

+492418035881

gheuer@ukaachen.de

Germany1 site, 1 recruiting
  • Universitätsklinikum Aachen

    Aachen, North Rhine-Westphalia, 52074

    Universitätsklinikum Aachen, 02418035881, gheuer@ukaachen.de

    Mohammad E Barbati, MD

    Recruiting

Other trials in Germany

About this study

Assessment of the Relationship between Severity of Chronic Venous Obstruction and Venous Claudication

Read the detailed description

The postthrombotic syndrome (PTS) occurs in about 20-50% of patients after a deep Venous thrombosis and significantly affects the quality of life of patients. With the patency rates of 73-100% are achieved with endovascular procedures. At 58% of patient ulcer healing was achieved. Neglen et al. could a significant demonstrate an improvement in quality of life. Aim of the study: To show the influence of the increased inflow to venous Objectively review recanalization for patient symptoms and walking performance. Therefore, before and after venous interventions, to assess walking performance and pain-free Measure the walking distance of the patient on the treadmill and compare it to get a possible identifying relevant and/or significant changes.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05662761
Study groupRoleWhat they receive
symptomatic chronic obstructionpatients with symptomatic chronic obstruction of the femoroiliac and caval vein segments (VFC, VIE, VIC, VCI) treated with stent angioplasty.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain -free walking distance

    pain-free walking distance after venous recanalization and stent implantation

    Measured: 2022-2025

Secondary outcomes (2)
  1. Stent openness rate

    Stent openness rate

    Measured: 2022-2025

  2. 2

    Quality of life of the patients after venous recanalization and stent-lmpl.antption

    Measured: 2022-2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2022
  2. Study start31 Mar 2022
  3. Primary completion30 Dec 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
24 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT05662761
Sponsor's protocol ID
Universitätsklinikum Aachen
Acronym
TIRED
Status last verified
Dec 2022
First submitted
1 Dec 2022
Last updated
22 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Venous Insufficiency, run by RWTH Aachen University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohammad E Barbati, MD (+492418035292, mbarbati@ukaachen.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain -free walking distance (time frame: 2022-2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2022; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in